The efficacy of prostate-specific antigen screening: Impact of key components in the ERSPC and PLCO trials.

Added 1621 days ago (07.12.2017)
Authors: de Koning HJ, Gulati R, Moss SM, Hugosson J, Pinsky PF, Berg CD, Auvinen A, Andriole GL, Roobol MJ, Crawford ED, Nelen V, Kwiatkowski M, Zappa M, Luján M, Villers A, de Carvalho TM, Feuer EJ, Tsodikov A, Mariotto AB, Heijnsdijk EAM, Etzioni R
PubMed id: 29211316
Read article